Study of Neuromuscular Electrical Stimulation to Increase Spontaneous Physical Activity in Obesity Patient (STIMOBIII)
Primary Purpose
Obesity, Number of Steps Per Day < 7000
Status
Active
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Rehabilitation
Sponsored by
About this trial
This is an interventional treatment trial for Obesity
Eligibility Criteria
Inclusion Criteria:
- Obese patients with BMI > 35 kg/m²
- CPAP treatment and > 4h observance per night to the patient with SAS
- Patients who give written consent
- Patients who subscribed social insurance
Exclusion Criteria:
- Cardiovascular or respiratory failure discovered at the moment of the inclusion in the study
- Contraindication to exercise
- Pregnant or breast-feed woman
- Patients under guardianship
- Imprisoned patients
Sites / Locations
- Hôpital Universitaire de Grenoble
- Hôpital universitaire de Lyon
- Hôpital universitaire de Saint Etienne
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Kneehab
Placebo
Arm Description
5 sessions per week
5 sessions per week
Outcomes
Primary Outcome Measures
Change in physical activity
Number of steps per day
Number of METs per day
Secondary Outcome Measures
Changes in body composition
Fat mass and fat-mass index as assessed by impedancemetry measurements
Change in arterial stiffness
Pulse wave velocity
Change in endothelial function
Peripheral arterial tone (RH-PAT)
Change in plasmatic biomarkers
Oxidative stress and inflammatory blood parameters
Change in quality of life
SF-12 questionnaire
Number of cardiovascular events per year
Questionnaire sent to the patient by mail
Change in other parameters of physical activity
Energy expenditure (total and during daily activities)
Change in sleep quality
Lying and sleep duration
Full Information
NCT ID
NCT02210585
First Posted
August 5, 2014
Last Updated
June 9, 2022
Sponsor
University Hospital, Grenoble
1. Study Identification
Unique Protocol Identification Number
NCT02210585
Brief Title
Study of Neuromuscular Electrical Stimulation to Increase Spontaneous Physical Activity in Obesity Patient
Acronym
STIMOBIII
Official Title
Study of Multi-site Neuromuscular Electrical Stimulation to Increase Spontaneous Physical Activity in Obesity Patient Carrying Severe Inactive: Randomized Controlled Trial vs Placebo
Study Type
Interventional
2. Study Status
Record Verification Date
June 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 9, 2014 (Actual)
Primary Completion Date
September 2022 (Anticipated)
Study Completion Date
March 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Grenoble
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The study was designed to test the following hypotheses:
Main Objective:
To compare the level of spontaneous physical activity at 3 months after re-entrainment by multi-site electrical stimulation (m-ES), measured by actigraphy over 7 days, compared to conventional care (lifestyle and dietary advice and placebo (simulated) electrostimulation) (control arm).
Secondary Objectives:
To compare the metabolic, inflammatory, cardiovascular and functional parameters, physical activity, quality of life and quality of sleep, at 3 months and at 2 years in the two groups.
Design:
We will conduct a multicenter controlled study vs. reference care with randomization into two parallel groups and double-blind (placebo electrostimulation). Patients will have the ES material available at home and will be supervised by monthly visits over 3 months and by telephone follow-up for two years. The study size calculation is based on physical activity, the percentage of lean body mass and arterial stiffness measured in the OBEX study.
This project will determine whether the training strategy is effective for increasing physical activity and/or in inducing significant metabolic and cardiovascular effects in these patients after 2 years. In addition, it provides a solid base of investigation for the study of the interactions between muscle contraction and cardio-metabolic health with greater precision.
Detailed Description
Obesity and sleep apnea syndrome lead to metabolic troubles and increasing cardiovascular risk. Furthermore, both diseases are associated with reduced exercise tolerance.
For many patients with morbid obesity, the implementation of physical activity programs remains difficult for several reasons including the level of disability and psychosocial causes (the scrutiny of others, depression and poorly adapted equipment).
Main hypothesis: Neuromuscular electrostimulation is a way to increase spontaneous physical activity (PA) in treated apneic obese patients with low spontaneous physical activity
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Number of Steps Per Day < 7000
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
73 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Kneehab
Arm Type
Active Comparator
Arm Description
5 sessions per week
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
5 sessions per week
Intervention Type
Other
Intervention Name(s)
Rehabilitation
Intervention Description
12 weeks : 5 sessions per week (1 supervised session at home every month)
92 weeks : spontaneous training (supervised by phone every month)
Primary Outcome Measure Information:
Title
Change in physical activity
Description
Number of steps per day
Number of METs per day
Time Frame
After a period of monthly supervised training program by neuromuscular electrical stimulation at home (12th wk)
Secondary Outcome Measure Information:
Title
Changes in body composition
Description
Fat mass and fat-mass index as assessed by impedancemetry measurements
Time Frame
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and during a period of spontaneous training (48 th, 72 th, 96 th week)
Title
Change in arterial stiffness
Description
Pulse wave velocity
Time Frame
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and during a period of spontaneous training (48 th, 72 th, 96 th week)
Title
Change in endothelial function
Description
Peripheral arterial tone (RH-PAT)
Time Frame
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and after a period of spontaneous training (92th week )
Title
Change in plasmatic biomarkers
Description
Oxidative stress and inflammatory blood parameters
Time Frame
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and after a period of spontaneous training (92th week )
Title
Change in quality of life
Description
SF-12 questionnaire
Time Frame
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and after a period of spontaneous training (92th week )
Title
Number of cardiovascular events per year
Description
Questionnaire sent to the patient by mail
Time Frame
Every year from the 1st to the 2th year
Title
Change in other parameters of physical activity
Description
Energy expenditure (total and during daily activities)
Time Frame
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and during a period of spontaneous training (48 th, 72 th, 96 th week)
Title
Change in sleep quality
Description
Lying and sleep duration
Time Frame
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and during a period of spontaneous training (48 th, 72 th, 96 th week)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Obese patients with BMI > 35 kg/m²
CPAP treatment and > 4h observance per night to the patient with SAS
Patients who give written consent
Patients who subscribed social insurance
Exclusion Criteria:
Cardiovascular or respiratory failure discovered at the moment of the inclusion in the study
Contraindication to exercise
Pregnant or breast-feed woman
Patients under guardianship
Imprisoned patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Renaud TAMISIER, Pr
Organizational Affiliation
Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Universitaire de Grenoble
City
Grenoble
ZIP/Postal Code
38043
Country
France
Facility Name
Hôpital universitaire de Lyon
City
Lyon
ZIP/Postal Code
69310
Country
France
Facility Name
Hôpital universitaire de Saint Etienne
City
Saint Etienne
ZIP/Postal Code
42055
Country
France
12. IPD Sharing Statement
Learn more about this trial
Study of Neuromuscular Electrical Stimulation to Increase Spontaneous Physical Activity in Obesity Patient
We'll reach out to this number within 24 hrs